GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
304.87B
MGRIX
Price
$26.88
Change
+$0.19 (+0.71%)
Updated
Jun 6 closing price
Net Assets
409.83M
Interact to see
Advertisement

GAFFX vs MGRIX

Header iconGAFFX vs MGRIX Comparison
Open Charts GAFFX vs MGRIXBanner chart's image
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets304.87B
Marsico Growth
Price$26.88
Change+$0.19 (+0.71%)
VolumeN/A
Net Assets409.83M
GAFFX vs MGRIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. MGRIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and MGRIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. MGRIX (410M). GAFFX pays higher dividends than MGRIX: GAFFX (0.65) vs MGRIX (0.00). GAFFX was incepted earlier than MGRIX: GAFFX (8 years) vs MGRIX (27 years). MGRIX (1.33) is less costly to investors than GAFFX (0.30). MGRIX is a more actively managed with annual turnover of: 89.00 vs. GAFFX (25.00). MGRIX has a lower initial minimum investment than GAFFX: MGRIX (2500) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. MGRIX (8.50). GAFFX return over 5 years is better than : 47.05 vs. MGRIX (25.54).
GAFFXMGRIXGAFFX / MGRIX
Total Expense Ratio0.301.3323%
Annual Report Gross Expense Ratio0.301.3323%
Fund Existence8 years27 years-
Gain YTD5.6403.170178%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets305B410M74,390%
Annual Yield % from dividends0.650.00-
Returns for 1 year9.748.50115%
Returns for 3 years38.5662.3562%
Returns for 5 years47.0525.54184%
Returns for 10 yearsN/A23.17-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc